Could using an inhaler only when needed beat daily asthma pills?
NCT ID NCT05111262
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at whether people with asthma who often forget to take their daily maintenance inhaler might do better using an inhaler only when they have symptoms. Researchers will compare adherence and asthma flare-ups between two groups: one continuing daily maintenance inhalers plus a rescue inhaler, and the other using a symptom-driven combination inhaler. The trial involves 60 participants aged 12-75 with mild to moderate asthma.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
budesonide/formoterol (symptom-driven inhaler)
What this could lead to
If successful, this could offer a simpler, more effective way for people with asthma to manage their condition without needing daily maintenance inhalers.
What could go wrong
This is an early pilot study with only 60 participants, so results may not apply to everyone. The symptom-driven approach may not control asthma as well as daily inhalers for some people.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Washington University in St. Louis School of Medicine
St Louis, Missouri, 63110, United States